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Three monoclonal antibodies, designated MAb 16E6, MAb 13C4, and MAb 19G8, were produced which
recognize Shiga-like toxin (SLT) from Escherichia coli. All three monoclonal antibodies neutralized the
cytotoxicity of E. coli SLT and were able to immunoprecipitate intact labeled toxin with Staphylococcus aureus
protein A. The three antibodies were of the Gl heavy and kappa light chain classes. MAb 16E6 bound to the
B subunit of SLT in Western blots and also neutralized the lethality of the toxin for mice and the enterotoxicity
of the toxin in ligated rabbit ileal loops. The ability of MAb 16E6 to neutralize the cytotoxicity, lethality, and
enterotoxicity of E. coli confirms the hypothesis that all three activities are associated with a single toxin. MAb
16E6 and MAb 13C4 also neutralized the cytotoxicity of purified Shiga toxin from ShigeUla dysenteriae type 1
and Shiga-like toxic activities in crude cell extracts from Shigella flexneri, Vibrio cholerae, Vibrio
parahaemolyticus, and Salmonella typhimurium. Thus, Shiga toxin and the SLTs from E. coli, Shigellaflexneri,
V. cholerae, V. parahaemolyticus, and Salmonella typhimurium share a common B subunit epitope that is
involved in neutralization. MAb 13C4 has been successfully used in a colony blot assay for the detection of
bacterial colonies which produce high levels of SLT. Sixty-two different strains of bacteria were tested by both
the cytotoxicity and colony blot assays for the presence of SLT. The colony blot assay detected all strains of
bacteria which produce -10 50% cytotoxic doses of SLT per ml of sonic lysate. There were no false-positive
results among the 62 samples tested.
In addition to its heat-stable and heat-labile enterotoxins,
Escherichia coli has been reported to produce another toxin
which has enterotoxic activity. This toxin, referred to either
as Verotoxin or Shigella dysenteriae 1 (Shiga)-like toxin
(SLT), was first described in 1977 by Konowalchuk et al.
(11). Like Shiga toxin, the SLT of E. coli is enterotoxic for
ligated rabbit ileal loops, paralytic and lethal for mice, and
cytotoxic for selected cell lines in vitro (18). The cytotoxicity
of SLT is also neutralized by polyclonal antiserum against
Shiga toxin (20). SLT contains one A subunit and several
copies of a B subunit (18). However, the function of each
subunit of SLT has not been directly demonstrated. Studies
with the prototype Shiga toxin (4, 23) indicate that its A
subunit contains the biologically active portion of the toxin
while its B subunit contains binding component(s). The SLT
of E. coli has been implicated as a possible virulence factor
in the pathogenesis of certain diarrheal diseases (3, 27, 28,
32), hemorrhagic colitis (12, 13, 21, 25), and hemolytic
uremic syndrome (10, 29). However, collection of epidemi-
ological data on the association of SLT production with
disease has been hampered by the fact that the methods
currently available for screening of E. coli for SLT are
expensive, time consuming, and labor intensive. Moreover,
attempts to develop immunochemical tests to detect toxin-
producing bacteria in our laboratory have been hampered by
the presence of cross-reacting antibacterial antibodies in
polyclonal antitoxin and normal sera. The use of monoclonal
antibodies rather than polyclonal antisera should improve
the specificity of immunochemical tests for the detection of
SLT.
Monoclonal antibodies have been produced against the
heat-stable enterotoxin of E. coli (2), heat-labile toxin of E.
coli (1), cholera toxin from V. cholerae (9, 15, 24, 26), and
Shiga toxin from Shigella dysenteriae type 1 (4, 8). These
* Corresponding author.
monoclonal antibodies have been helpful in cross-
neutralization studies, epitope-mapping experiments, and in
the development of rapid diagnostic tests for the presence of
various antigens in patient and food samples. In this paper,
we describe the production and characterization of three
monoclonal antibodies against SLT and the successful use of
one of these antibodies in the development of an assay to
detect high-SLT-producing bacteria growing on agar plates.
MATERIALS AND METHODS
Bacterial strains. The bacteria used in this study were
obtained from J. G. Wells, J. J. Farmer, and I. K.
Wachsmuth of the Center for Disease Control, Atlanta, Ga.;
M. A. Karmali of the Hospital for Sick Children, Toronto,
Ontario, Canada; S. B. Formal of the Walter Reed Army
Institute of Research, Washington, D.C.; H. W. Smith of the
Houghton Poultry Research Station, Huntingdon, Cam-
bridgeshire, United Kingdom; L. R. Trabulsi of the Escola
Paulista de Medicina, Sao Paulo, Brazil; D. Sherwood of the
Moredun Research Institute, Edinburgh, United Kingdom;
M. Levine and J. Kaper of the Center for Vaccine
Development, Baltimore, Md.; T. Mapes of the National
Naval Medical Center, Bethesda, Md.; and lysogens
constructed in this laboratory. The strains were stored frozen
at -70°C and maintained in the laboratory by periodic
transfer on tryptic soy agar slants.
Toxin purification. Shiga toxin from Shigella dysenteriae
type 1 strain 60R and SLT from E. coli H30 were prepared
and purified by published techniques (18, 19).
Production and purification of monoclonal antibodies.
BALB/c mice (female, 6 to 8 weeks old) were immunized
with purified, biologically active SLT from E. coli H30. The
mice were periodically bled from the orbital plexus to assess
the titers of neutralizing antibody. Four mice were immu-
nized with 0.4 to 1.6 ,ug of purified toxin on days 1, 37, 54,
83, and 101. The toxin was administered intraperitoneally in
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Freund complete adjuvant (1:1; Difco Laboratories, Detroit,
Mich.) (1:1) on day 1, subcutaneously in Freund incomplete
adjuvant (1:1; Difco) on day 37, intraperitoneally in phos-
phate-buffered saline (PBS) on day 54, and intravenously in
PBS on days 83 and 101. On day 105, two mice were
sacrificed by cervical dislocation for use in fusion 1. To the
remaining mice, toxin (1.0 ,ug in PBS) was administered
intraperitoneally on days 174, 175, 176, and 177. On day 178,
toxin (1.0 ,ug in PBS) was administered intravenously, and
on day 179, the mice were sacrificed for fusion 2.
Cell fusion with splenocytes and SP2/0-Ag 14 myeloma
cells, selection, and growth of hybrids were performed as
described previously (16). Cell culture supernatants were
screened for toxin-specific antibodies by a cytotoxin neutral-
ization assay with purified E. coli H30 toxin as previously
described (6). Positive hybrids were subcloned twice by
limiting dilution at 1 and 0.1 cells per well and retested for
antibody production by neutralization. Isotypes were deter-
mined by immunodiffusion with class-specific antisera
(Litton Bionetics, Kensington, Md.).
Assays with monoclonal antibodies were performed with
either unconcentrated or concentrated culture supernatants.
Concentrated culture supernatants were prepared by precip-
itation with 50% saturated ammonium sulfate (pH 7.0) fol-
lowed by dialysis against 0.1 M phosphate buffer (pH 7.4).
Immunoprecipitation of SLT by monoclonal antibodies.
Immunoprecipitation of toxin-monoclonal antibody com-
plexes with Staphylococcus aureus was performed as de-
scribed previously (30). Radioiodination of purified SLT
from E. coli H30 was performed by the chloramine T method
by published procedures (18). Proteins immunoprecipitated
by the monoclonal antibodies were resolved by electropho-
resis on sodium dodecyl sulfate-15% polyacrylamide gels
(14) and identified by fluorography in the presence of X-
Omatic regular intensifying screens (Eastman Kodak Com-
pany, Rochester, N.Y.).
Immunoblot analysis of monoclonal antibodies. Purified
SLT from E. coli H30 was separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis with 15%
acrylamide gels (approximately 50 ,ug of toxin per gel) (14).
When electrophoresis was completed, the gels were re-
moved, and the separated toxin subunits were electropho-
retically transferred to nitrocellulose paper (pore size, 0.45
,um; BA 85; Schleicher & Schuell, Inc., Keene, N.H.) BA
85, 0.45 jim) essentially as described by Towbin et al. (31).
The nitrocellulose paper-gel sandwich was electrophoresed
overnight under a constant current of 150 mA at 10°C. After
electrophoresis, the nitrocellulose paper was stained im-
munochemically or with amido black (0.1% [wt/vol]). All
manipulations of the nitrocellulose paper were done at room
temperature. Immunochemical staining was performed by
first blocking the paper with 3% (wt/vol) gelatin in Tris-
buffered saline (TBS; 20 mM Tris hydrochloride, 500 mM
NaCl; pH 7.5) for 30 min and then incubating it with
monoclonal antibodies (undiluted culture supernatants). The
nitrocellulose paper was then washed with TBS (three
15-min washes with 200 ml of buffer per wash) and subse-
quently stained for 3 h with horseradish peroxidase-
conjugated goat anti-mouse immunoglobulin G (IgG) (whole
molecule) (Sigma Chemical Co., St. Louis, Mo.) diluted
1:2,000 in TBS-1% (wt/vol) gelatin. The nitrocellulose paper
was washed as described above and developed in TBS
containing 0.05% (wt/vol) 4-chloro-1-napthol and 0.015%
(vol/vol) hydrogen peroxide for 30 min.
Biological assays. (i) Rabbit ileal loop assay. Ammonium
sulfate-concentrated culture supernatants of monoclonal an-
tibody 16E6 (MAb 16E6) and MAb 32D3 (negative control,
IgGl/kappa anti-cholera toxin; for additional description see
reference 9) were tested for their ability to neutralize the
enterotoxic effects of purified SLT from E. coli H30. Three
milliliters of antibody solution and 3 ml of toxin (0.66 jig of
toxin per ml diluted in PBS containing 0.1% [wt/vol] gelatin)
were mixed and incubated 1 h at 37°C and overnight at 4°C.
The antibody-toxin solution (1 ml per loop) was tested for
enterotoxicity in the rabbit ileal loop assay by published
procedures (5).
(ii) Cytotoxicity assay for SLT. Sonic lysates at various
dilutions or culture supernatants at a 1:100 dilution were
tested for cytotoxicity on HeLa cells as previously described
(6). Neutralization of Shiga toxin and SLT was performed by
published procedures (6). Neutralization of the cytotonic
effect of heat-labile enterotoxin (LT), LT-like toxin, and
cholera toxin for Y-1 adrenal cells was also performed by
published procedures (7, 9).
(iii) Mouse lethality. Ammonium sulfate-concentrated cul-
ture supernatants of MAb 16E6 and MAb 32D3 were tested
for their ability to neutralize the lethality for mice of purified
SLT from E. coli H30. The samples were prepared by using
the same antibody and toxin stock solutions used for the
enterotoxicity neutralization study. One microgram of toxin
was mixed with the undiluted monoclonal antibody solution
and incubated as described for the enterotoxicity assay. The
neutralized samples were tested for lethality in CD-1 mice
(female, 30 to 35 g; Charles River, Kingston, N.Y.) as
previously described (22).
Colony blot assay for the detection of SLT. Syncase agar
plates were prepared by mixing modified syncase broth (20)
with Noble agar (final concentration, 1.5% [wt/vol]; Difco)
and Chelex 100 (final concentration, 2% [wt/vol]; Bio-Rad
Laboratories, Richmond, Calif.) for 2 h at room temperature
with stirring. After Chelex treatment, the whole mixture
(agar and Chelex) was autoclaved at a pressure of 15 lb/in2
and a temperature of 121°C for 30 min. Immediately before
the plates were poured, trimethoprim and sulfamethoxazole
(Septra; intravenous infusion, 16 mg of trimethoprim per ml
and 80 mg of sulfamethoxazole per ml; Burroughs-Wellcome
Co., Research Triangle Park, N.C.) was added to give a final
concentration of 0.021 jig of trimethoprim per ml and 0.104
jig of sulfamethoxazole per ml in the agar.
Bacterial colonies were inoculated on Chelex-treated
syncase agar containing trimethoprim and sulfamethoxazole
and incubated 18 to 24 h at 37°C. Dry nitrocellulose mem-
branes (diameter, 82 mm; pore size, 0.45 jim; Millipore
Corp., Bedford, Massachusetts, or Schleicher & Schuell)
were then placed on top of the colonies and allowed to
absorb moisture from the plates. Bubbles trapped between
the nitrocellulose membranes were expressed manually, and
2 ml of polymyxin B solution (2 mg of polymyxin B sulfate
[Sigma] per ml in PBS) were layered over the membranes
and allowed to permeate the membranes for 45 min at 37°C
to release toxin from the bacteria. The liberated toxin was
bound by the membrane, and the bacterial debris adhering to
the membranes was washed off with TBS (pH 7.5). Identical
membranes were prepared for staining with positive and
negative monoclonal antibodies. Precautions for infectious
material were taken during the blotting and staining proce-
dures since viable organisms had been observed to remain
on the plates after the polymyxin B treatment.
After the toxin was released from the bacteria, the blots
were stained immunochemically for the presence of SLT.
Immunochemical staining was performed as follows: (i) the
blots were blocked with 3% (wt/vol) gelatin in TBS for 30
INFECT. IMMUN.
MONOCLONAL ANTIBODIES TO E. COLI SHIGA-LIKE TOXIN
TABLE 1. Characterization of monoclonal antibodies
Characteristica
Neutralization of the following SLT
Monoclonal Holotoxin activity
antibody immuno-Mos
precipitation Cytotoxicity Enterotoxicity Mouselethality
MAb 16E6 + + + +
MAb 13C4 + + NT +
MAb 19G8 + + NT NT
a All three monoclonal antibodies are of the IgG1/kappa isotype. MAb 16E6
and MAb 13C4 exhibited binding specificity for B subunit in Western blots.
MAb 19G8 was not reactive. NT, Not tested.
min at room temperature with gentle agitation, and (ii) the
blots were incubated for 2 to 3 h at room temperature or
overnight at 4°C with either monoclonal antibodies (positive
or negative) or rabbit sera (immune or normal). A 1:10
dilution (in TBS-1% [wt/vol] gelatin) of culture supernatants
containing monoclonal antibodies or a 1:2,500 dilution of
rabbit serum was used in the first incubation.
Unbound antibody was removed by three 15-min washes
with TBS at room temperature. The blots were then in-
cubated with an enzyme-linked second antibody (1:3,000
dilution of goat anti-mouse IgG [heavy and light chain]-
horseradish peroxidase conjugate in TBS-1% [wt/vol] gela-
tin; Bio-Rad Laboratories) for 1.5 to 2 h at room temperature
with gentle agitation. Unbound second antibody was re-
moved as described above. The blots were developed with
0.05% (wt/vol) 4-chloro-1-napthol And 0.015% (vol/vol) hy-
drogen peroxide in TBS at room temperature with gentle
agitation for 30 min. After development, the membranes
were rinsed with deionized water and photographed while
wet.
RESULTS AND DISCUSSION
Isolation and characterization of monoclonal antibodies.
Three hybrid cell lines, designated 16E6, 13C4, and 19G8,
were recovered and cloned from two fusions involving the
SP2/0-Ag 14 myeloma cell line and spleen cells from BALB/c
mice immunized against purified, biologically active SLT
from E. coli H30. Approximately 2,000 hybrids were
screened from the two fusions. Hybrid cell line 16E6 was
isolated from fusion 1, and lines 13C4 and 19G8 were derived
from fusion 2.
The limiting factor in the development of monoclonal
antibodies against SLT was the availability of purified toxin
for immunizations, screening assays, and characterization
studies. The purification of SLT routinely took 3 weeks, and
the yield of pure toxin from an 8-liter culture was only
approximately 200 Rg. Large amounts of toxin were ex-
pended in an attempt to develop an enzyme-linked im-
munosorbant assay for the detection of nonneutralizing
antibodies. These efforts were, in practical terms, not suc-
cessful, due to the need for quantities of toxin that were not
feasible for routine screening. The only sensitive and specific
assay available in our laboratory for identifying antitoxin
antibodies was the neutralization assay which was used as
the screening assay for both fusions. Genetic studies are in
progress to obtain larger quantities of holotoxin as well as A
and B subunits alone. Once available, these reagents should
facilitate the production of additional monoclonal antibodies
for epitope-mapping studies.
Table 1 summarizes the results of the antibody character-
ization studies. All three antibodies were of the IgGl heavy
chain and kappa light chain class. All three antibodies
immunoprecipitated the holotoxin (Fig. 1) and neutralized
the cytotoxicity of the toxin (Table 1). Western blot analysis
showed that MAb 16E6 and MAb 13C4 recognized the B
subunit of the toxin (Table 1; data not shown). MAb 16E6
was also shown to neutralize both the lethality of the toxin
for mice and the enterotoxicity of the toxin in ligated rabbit
ileal loops. The neutralization of the three biological activi-
ties of purified SLT by MAb 16E6 supports the hypothesis
that the three activities are associated with a single toxin
molecule and that neutiralization of these three activities by
this monoclonal antibody involves a determinant on the B
subunit.
Neutralization studies with MAb 16E6 and MAb 13C4
were performed to evaluate the antigenic relatedness of
several enterotoxins. MAb 16E6 and MAb 13C4 neutralized
the cytotoxicity of purified Shiga toxin from Shigella
dysenteriae type 1 strain 60R; purified SLT from E. coli H30
(026); and crude SLT from E. coli 933 (0157:H7), E. coli
H19, E. coli (K-12) C600, Shigella flexneri M4243, V.
parahaemolyticus FC1011, V. cholerae JBK70, arid Salmo-
nella typhimurium W118. In Y-1 adrenal cells, MAb 16E6
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FIG. 1. Staphylococcus aureus protein A immunoprecipitation
of 'l25-labeled SLT by monoclonal antibodies. Lanes A, B, and C
contain the immune precipitates obtained with anti-SLT MAb 16E6,
MAb 13C4, and MAb 19G8, respectively. Lanes D and E contain the
precipitates obtained with anti-cholera toxin MAb 32D3 and MAb
34B6, respectively. '4C-labeled molecular weight standards
(Bethesda Research Laboratories, Inc., Gaithersburg, Md.) are
included in the center and side lanes.
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and MAb 13C4 did not neutralize the cytotonic activity of
purified cholera toxin, purified LT of porcine or human
origin, or LT-like toxin from E. coli. These, neutralization
studies confirm earlier observations (20) that Shiga toxin and
SLT are antigenically related and that Shigella flexneri, V.
parahaemolyticus, V. cholerae, and Salmonella typhi-
murium produce SLT (17).
Rapid epidemiologic screening for E. coli strains that pro-
duce high levels of SLT. To facilitate the detection of bacteria
producing high levels of SLT, a colony blot assay was
developed. Two events contributed to the successful devel-
opment of the colony blot assay. These were (i) the produc-
tion of SLT-specific monoclonal antibodies and (ii) the
observation that subinhibitory concentrations of the antibi-
otics trimethoprim and sulfamethoxazole increased, the pro-
duction of toxin for E. coli 933 (H. Karch, A. D. O'Brien, P.
Goroncy, and W. Opferkuch, Abstr. Annu. Meet. Am. Soc.
Microbiol., 1985. Blll, p. 36).
Figure 2 compares the results of colony blot assays
performed with monoclonal antibodies and with rabbit poly-
clonal antisera. SLT in 33 of the 62 different strains tested
was detected by MAb 13C4. There was no background
staining with MAb 32D3, the negative control antibody
(IgGl/kappa) directed against the B subunit of cholera toxin
(9). In cohtrast, SLT in bacterial colonies stained with the
polyclonal rabbit sera was not readily discernible due to a
high level of background staining by the normal serum. The
staining intensity noted among the different strains of bacte-
TABLE 2. Neutralization of several bacterial enterotoxins with
MAb 16E6 and MAb 13C4
Neutral-
Test culture, toxin' Source strain izationof
activityb
HeLa cells
SLT (purified toxin) Esferichia coli +
H-30 (026)
SLT (crude cell extract) Escherichia coli H19 +
, tO26)
SLT (crude cell extract) EscRerichia coli 933 +
(0157:H7)
SLT (crude cell extract) Escherichia coli (K-12) +
C600
SLT (crude cell extract) Vibrio cholerae JBK70 +
SLT (crude cell extract) Vibrio parahaemolyticus +
FC1011
SLT (crude cell extract) Salmonella typhimurium +
W118
SLT (crude cell extract) Shigella flexneri M4243 +
2A
Shiga toxin (purified toxin) Shigella dysenteriae type +
1 strain 60R
Y-1 adrenal cells
LTh (purified toxin) Escherichia coli -
HE22pTD2
LTp (purified toxin) Esiherichia coli HE12 -
LT-like toxin (partially Escherichia coli SA-53 -
purified toxin)
CT (purified toxin) Vibrio cholerae 569B -
a Abbreviations: SLT, Shika-like toxin; LTh, LT purified from a human
isolate; LTp, LT purified from a porcine isolate; CT, cholera toxin.
b Shiga toxin and SLT kill HeLa cells but do not effect Y-1 adrenal cells.
LT, LT-like toxin, and CT do not effect HeLa cells but cause rounding






FIG. 2. Colony immunoblot assay for the detection of SLT in
bacteria on agar plates. Nitrocellulose membranes containing
polymyxin B-released toxin were stained with monoclonal antibod-
ies against SLT (13C4, +MAb), monoclonal antibody against chol-
era toxin (32D3, -MAb), anti-Shiga toxin immune rabbit serum
(IRS), or normal rabbit serum (NRS). The mo.noclonal antibodies
were used at a 1:10 dilution of the culture supernatants, and the
rabbit sera were used at a 1:2,500 dilution.
ria tested by using the polyclonal antisera did not correlate
with the presence of SLT.
The strains studied in the colony blot assay had previously
been tested for the levels of SLT in the sonic lysates using
the cytotoxicity assay (L. R. M. Marques, M. A. Moore,
J. G. Wells, I. K. Wachsmuth, and A. D. O'Brien, manu-
script in preparation). The bacteria in that study were
classified as high, low to moderate, or trace toxin producers
by the following criteria: high toxin producers made i105
50% cytotoxic doses (CD50)/ml in the sonic lysate; low to
moderate toxin prdducers made 6 x 102 to 104 CD50/ml in the
sonic lysate; and trace producers made <6 x 102 CD50 per ml
in the sonic lysate. When analyzed with respect to the level
of toxin produced, the colony blot assay appeared to be
sensitive for the identificatioh of high-SLT-producing bacte-
ria (Fig. 3). All strains classified as high toxin producers
were positive in the colony blot assay, while all strains that
were classified as low to moderate or trace toxin producers
were negative in the blot assay.












FIG. 3. Comparison of colony blot staining anq level of toxin
production as assessed by the cytotoxicity assay. Thq results of the
colony blot assay are presented on tbr, abscissa as positive (any
detectable staining above background) pr negative.'The toxin level
of a particular organism is shown on the ordinate. Each point
represents one culture. Bacteria classified a§ high toxin producers
made i105 CDs5/ml in the sonic lysate while low to moderate toxin
producers made 6 x 102 to 104 CD50/ml, and trace toxin producers
made <6 x 102 CD5diml in the sonic lysate. Strains' for which
serotype information was available were distributed as follows
among the high, low-to-moderate, or trace categories: E. coli
serotypes 0157:H7, 026:H11, 0111:H-, 0111:H?, 0146:H?, and
0103:H2 were high toxin producers and were positive in the colony
blot assay; E. coli serotype 09:H4 apd Shigellaflexneri serotype 2A
were low to moderate to'xin producers and were negative in the
colony blot assay; and E. coli serotypes 055:H6, 0145:-H4, and
0145:-H were trace toxin producers and were negative in the
colony blot assay. The remaining serotypes were not determined.
Twelve of the high toxin producers tested in this study
were E. coli of the serotype 0157:H7. All samples of this
serotype were categorized as high toxin producers in the
cytotoxicity assay, and atll of these were positive in the
colony blot assay. Since E. coli 0157:H7 cells have been
implicated as etiologic a,gents in'several cases of food-borne
hemorrhagic colitis (3, 27, 28, 32) as well as patients with
hemolytic uremic syndrome (10, 29), the detection of these
bacteria in patient and food samples is desirable. Where
tissue culture facilities are not available or extensive bacte-
riologic workups are not practical, the colony blot assay may
be a useful screening test for the identification of bacteria
which make high levels of SLT.
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